Completed NA INTERVENTIONAL 2-arm NCT04391504

Intracardiac Versus Transesophageal Echocardiography for Left Atrial Appendage Occlusion Combined With Radiofrequency Ablation

Sponsor: Ruiqin xie

Interventions LAAC combined with radiofrequency ablation group

Updated 8 times since 2020 Last updated: May 4, 2022 Started: May 1, 2020 Primary completion: Apr 1, 2022 Completion: Apr 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04391504, this NA trial focuses on Atrial Fibrillation and remains completed. Sponsored by Ruiqin xie, it has been updated 8 times since 2020, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Oct 2021 — Jun 2022 [monthly]

Recruiting NA
Apr 2021 — Oct 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 3 earlier versions

Jan 2021 — Apr 2021 [monthly]

Not Yet Recruiting NA
Nov 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA
Jun 2020 — Nov 2020 [monthly]

Not Yet Recruiting NA

First recorded

May 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ruiqin xie

Data source: The Second Hospital of Hebei Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shijiazhuang, China